0001209191-24-001291.txt : 20240109
0001209191-24-001291.hdr.sgml : 20240109
20240109192206
ACCESSION NUMBER: 0001209191-24-001291
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240105
FILED AS OF DATE: 20240109
DATE AS OF CHANGE: 20240109
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Blackman Samuel C.
CENTRAL INDEX KEY: 0001863676
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40431
FILM NUMBER: 24524548
MAIL ADDRESS:
STREET 1: 395 OYSTER POINT BLVD.
STREET 2: SUITE 217
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Day One Biopharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001845337
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 832415215
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2000 SIERRA POINT PARKWAY, SUITE 501
CITY: BRISBANE
STATE: CA
ZIP: 94005
BUSINESS PHONE: 650 484-0899
MAIL ADDRESS:
STREET 1: 2000 SIERRA POINT PARKWAY, SUITE 501
CITY: BRISBANE
STATE: CA
ZIP: 94005
FORMER COMPANY:
FORMER CONFORMED NAME: Day One Biopharmaceuticals Holding Co LLC
DATE OF NAME CHANGE: 20210209
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2024-01-05
0
0001845337
Day One Biopharmaceuticals, Inc.
DAWN
0001863676
Blackman Samuel C.
2000 SIERRA POINT PARKWAY, SUITE 501
BRISBANE
CA
94005
0
1
0
0
Head of Research and Developme
0
Stock Option (right to buy Common Stock)
14.44
2024-01-05
4
A
0
148000
0.00
A
2034-01-04
Common Stock
148000
148000
D
Restricted Stock Units
2024-01-05
4
A
0
97000
0.00
A
Common Stock
97000
97000
D
The option vests as to 1/48th of the total shares monthly, commencing February 5, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's Common Stock upon settlement.
The RSUs vest as to 1/16th of the total award in quarterly installments on February 15, May 15, August 15 and November 15, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
/s/ Charles N. York II, as Attorney-in-Fact
2024-01-09